5 Best Weight Loss Drug Stocks to Buy Now

2. Merck & Co., Inc. (NYSE:MRK)

Number of Q4 2023 Hedge Fund Shareholders: 98

Merck & Co., Inc. (NYSE:MRK) is an American pharmaceutical giant headquartered in Rahway, New Jersey. Its weight loss drug efinopegdutide is also a candidate for treating liver damage from fat buildup.

Insider Monkey dug through 933 hedge fund portfolios for their fourth quarter of 2023 shareholdings and found that 98 were the firm’s investors. Merck & Co., Inc. (NYSE:MRK)’s largest hedge fund investor in our database is Ken Fisher’s Fisher Asset Management as it owns $1.4 billion worth of shares.

Follow Merck & Co. Inc. (NYSE:MRK)